Browse by article | Browse by volume |
If you want to download the article, please login or register as reader.
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 5 - 6) Treatment Expansion for Opioid Use Disorders in the United States Parrino M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 7 - 12) Capgras Syndrome in a Heroin Addict. A Case Study Lovrecic M., and Lovrecic B. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 13 - 20) Schoofs N., Häbel T.H., Bermpohl F., and Gutwinski S. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 21 - 30) Pombo S., and Félix da Costa N. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 31 - 36) Methadone Versus Torture: The Perspective of the European Court of Human Rights Junod V., Wolff H., Scholten W., Novet B., Greifinger R., Dickson C., and Simon O. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N1 (pages: 37 - 44) Van Hout M.C., Crowley D., Collins C., Barry A., Lyons S., and Delargy I. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 5 - 11) Methadone Dose as a Determinant of Infant Outcome During the Peri and Postnatal Period Wang M., Stapleton J., and Wolff K. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 13 - 22) Kałwa A., Siwy-Hudowska A., and Niznikiewicz M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 23 - 29) Heroin Deaths in Norway in 2000 and 2009: A Comparative Study of Polydrug Use Karinen R., Konstantinova-Larsen S., Normann P.T., Mørland J., Christophersen A.S., and Arnestad M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 31 - 33) Refractory Bipolar Patient Treated with Oral Methadone: Does Methadone Act as Mood Stabilizer? Etaee F., Shirdel S., Azarhomayoun A., Nasiri K., and Komaki A. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 35 - 40) Lovrecic M., Lovrecic B., Maremmani I., and Maremmani A.G.I. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N2 (pages: 41 - 50) How to Improve a Poorly Running Agonist Opioid Treatment (Aot). Part 5: Higher Dosage Ulmer A., and Meinhold C. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 5 - 12) The Second to Fourth Digit (2d:4d) Ratios in Patients with Heroin Use Disorder Canan F., Sogucak S., Karaca S., Tegin C., Gecici O., and Kuloglu M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 13 - 24) Lovrecic B., and Lovrecic M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 25 - 32) Evren C., Karabulut V., Alniak I., Umut G., Cetin T., Evren B., and Agachanli R. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 33 - 40) Abed M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 41 - 49) How to Develop and Implement an Exercise Programme in a Heroin-Assisted Treatment Setting Staub L., Gerber M., Vogel M., Dürsteler-Macfarland K., Strom J., Schoen S., Pühse U., and Colledge F. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N3 (pages: 51 - 58) Diversion of Buprenorphine: Scope of the Problem and the Measures Taken to Address It Tripathi R., and Sarkar S. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 5 - 11) Multidisciplinary Settings in the Treatment of Drug-Addiction: An Experimental Evaluation Cicatelli P., Borriello M.T., De Vivo C., D'Oriano V., Fuscone A., Moccia E., and Siconolfi M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 13 - 18) A Review of Literature Assessing Public Opinion of Heroin Assisted Treatment Berrigan P. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 19 - 28) Predictors of Retention and Mortality among Patients on Methadone Maintenance Therapy Teoh J., Yee A., and Danaee M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 29 - 35) Gimelfarb Y., Ligay A., and Ben Tzarfati M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 37 - 43) Barra M., Direnzo G.F.M., Patruno F.V., Patti M., Rodoquino G., Rossi E., Santoro R., and Badiani A. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N4 (pages: 45 - 54) Conversano C., Belcari I., Marchi L., Maremmani A.G.I., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 5 - 11) Addiction and self-reported associated sociodemographic factors in a small province of Iran Sedaghat Z., Fararouei M., Shahraki G., Karimzadeh Shirazi K., and Haghighi R.E. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 13 - 17) Barrett R., and Costa D. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 19 - 28) Reed K., Knight A., Baillie S., Bogdanowicz K., Bell J., and Strang J. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 29 - 34) Carbone M.G., Maiello M., Spera V., Manni C., Pallucchini A., Maremmani A.G.I., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 35 - 49) Hill D., Garner D., and Baldacchino A. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N5 (pages: 50 - 53) van Hout M.C. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 5 - 15) Monwell B., Bülow P., and Johnsson B. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 17 - 25) Emmerson O., Parkman T., Akhtar S., Lowe E., and Day E. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 27 - 34) Khazaie H., Jalali A., Cheraghi K., Mojtaba Ahmadi S., and Khaledi-Paveh B. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 35 - 37) Outbreak of 'Novel Synthetic Opioids': A Deadly Threat to Public Health Lovrecic B., and Lovrecic M. |
Heroin Addiction and Related Clinical Problems: 2018, 20, N6 (pages: 39 - 50) Personality Dimensions and Main Drug of Use in Dual Disorders Hurtado Ruiz M.G., Fonseca F., Díaz Digón L., Martínez Riera R., Martínez Sanvisens D., Mateu Codina G.A., Farre Martínez A., Sauras Quetcuti R.B., and Torrens M. |
EUROPAD - European Opiate Addiction Treatment Association Rolex replica
Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |